Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 908-300-1 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
A skin sensitisation study performed according to OECD 429 guideline was carried out with ScFOS (and GLP compliant). Under the experimental conditions, there was no evidence of sensitisation and the Stimulation Index (SI) calculated by pooled approach was 0.69, 0.73 and 0.65 for the treated groups at 5%, 10% and 25%, respectively.
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- September 2011
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
- Specific details on test material used for the study:
- • Sponsor’s identification: ACTILIGHT® 950P
• Form: powder
• Colour: White - Species:
- mouse
- Strain:
- CBA:J
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Elevage Janvier
- Females nulliparous and non-pregnant: yes
- Age at study initiation:8 or 9 weeks old.
- Weight at study initiation: weight range of 20.5 to 24.2 g
- Housing: individually housed in suspended solid-floor polypropylene cages furnished with softwood woodflakes.
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: at least five days under stabling and nutritional conditions identical to those of the test,
- Indication of any skin lesions: No
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19°C to 25°C
- Humidity (%): 30 to 70%,
- Air changes (per hr): approximately fifteen changes per hour
- Photoperiod (hrs dark / hrs light): the lighting was controlled by a time switch to give twelve hours continuous light (07.00 to 19.00) and twelve hours darkness. - Vehicle:
- dimethylformamide
- Concentration:
- The test item was diluted in dimethylformamide (DMF) at concentrations of 5% (v/v), 10% (w/w) and 25% (w/w).
- No. of animals per dose:
- Four animals per dose.
A further group of four animals was treated with DMF - Details on study design:
- PRE-SCREEN TESTS:
One mouse was treated by daily application of 25 μL of the test item diluted at 50% in dimethylformamide (DMF) to the dorsal surface of each ear for three consecutive days (Days 1, 2, 3). The mouse was observed daily from day 1. Any signs of toxicity or excessive local irritation noted during this period were recorded. Ear thickness was recorded on day 1, day 3 and on day 6. The bodyweight of the mouse was recorded
on Day 1 (prior to dosing) and Day 6.
MAIN STUDY
Groups of four mice were treated with the test item diluted at concentrations of 25% (w/w), 10% (w/w) and 5% (v/v) in the vehicle – dimethylformamide (DMF). The mice were treated by daily application of 25 μL of the appropriate concentration of the test item to the dorsal surface of each ear for three consecutive days (Days 1, 2, 3). The test item formulation was administered using an automatic micropipette and spread over the dorsal surface of the ear using the tip of the pipette.
A further group of four mice received the vehicle alone in the same manner.
ANIMAL ASSIGNMENT AND TREATMENT
the animals were selected at random and given a number unique within the study by indelible ink-marking on the tail and a number written on a cage card. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Positive control results:
- The assay has undergone extensive inter-laboratory validation and has shown to reliably detect test
materials that are moderate to strong sensitisers.
The strain of mouse used in these laboratories had been shown to produce satisfactory responses using known sensitisers and non-sensitisers during the in-house validation. - Key result
- Parameter:
- SI
- Value:
- 0.69
- Test group / Remarks:
- 5%
- Key result
- Parameter:
- SI
- Value:
- 0.73
- Test group / Remarks:
- 10%
- Key result
- Parameter:
- SI
- Value:
- 0.65
- Test group / Remarks:
- 25%
- Cellular proliferation data / Observations:
- Proliferative response of lymph node cells:
No stimulation index of more than 1.4 was recorded in the study, whatever the tested concentration of the test item.
The Stimulation Index (SI) calculated by pooled approach was 0.69, 0.73 and 0.65 for the treated groups at 5%, 10% and 25%, respectively.
The EC1.4 can not be determined in this study.
Local irritation:
No cutaneous reaction was noted on the treatment site of animals, whatever the administered concentration.
No significant increase in ear thickness and in ear weight was noted in animals treated at 5%, 10% and 25%. Therefore, the test item must be considered as non irritant at the three concentrations. - Interpretation of results:
- GHS criteria not met
- Conclusions:
- Under these experimental conditions, the test item ACTILIGHT® 950P must not be classified as a skin sensitiser, in accordance with Regulation EC No. 1272/2008 (CLP).
- Executive summary:
The test was performed to assess the skin sensitisation potential of the test item ACTILIGHT® 950P in the CBA/J strain mouse following topical applications to the dorsal surface of the ear.
The experimental protocol was established according the OECD Guideline No.429 dated 22 July 2010 and the test method B42 of the council regulation No. 440/2008. The study was GLP compliant.
Three groups of four animals were treated for three consecutive days (D1, D2, D3) with 50 μL (25 μL per ear) of the test item diluted in dimethylformamide (DMF) at concentrations of 5% (v/v), 10% (w/w) and 25% (w/w). A further group of four animals was treated with DMF.
On D6, the proliferation of lymphocytes in the draining auricular lymph nodes was determined by cell counting.
No mortality and no signs of systemic toxicity were noted in the test and control animals during the test.
No cutaneous reaction was noted on the treatment site of animals, whatever the administered concentration.
No significant increase in ear thickness and in ear weight was noted in animals treated at 5%, 10% and 25%. Therefore, the test item must be considered as non irritant at the three concentrations.
The Stimulation Index (SI) calculated by pooled approach was 0.69, 0.73 and 0.65 for the treated groups at 5%, 10% and 25%, respectively. The EC1.4 can not be determined in this study.
Under these experimental conditions, the test item ACTILIGHT® 950P must not be classified as a skin sensitiser.
Reference
- Clinical observations and mortality:
No mortality and no signs of systemic toxicity were noted in the test and controls animals during the test.
- Weight evolution:
Bodyweight changes of the test animals between Day 1 and Day 6 were comparable to those observed in the corresponding control group animals over the same period.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
The test was performed to assess the skin sensitisation potential of the ScFOS in the CBA/J strain mouse following topical applications to the dorsal surface of the ear, according the OECD Guideline No.429
Three groups of four animals were treated for three consecutive days (D1, D2, D3) with 50 μL (25 μL per ear) of the test item diluted in dimethylformamide (DMF) at concentrations of 5% (v/v), 10% (w/w) and 25% (w/w). A further group of four animals was treated with DMF.
No mortality and no signs of systemic toxicity, no cutaneous reaction were noted in the test and control animals during the test.
Under the test conditions, ScFOS must be considered as non-irritant at the three tested concentrations.
The Stimulation Index (SI) calculated by pooled approach was 0.69, 0.73 and 0.65 for the treated groups at 5%, 10% and 25%, respectively.
Testing was conducted according to a scientifically valid and accepted method (OECD 429). Hence, the obtained results can be considered as reliable.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
In view of the results of the LLNA test, the scFOS must not be classified as a skin sensitiser, in accordance with the Regulation EC No. 1272/2008. No signal word or hazard statement is required.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.